Global Medical REIT

Global Medical REIT reported Q2 results as it repositions from outpatient medical real estate into senior housing, investing $421 million in senior housing and selling seven inpatient rehabilitation facilities for about $200 million. Normalized same-store NOI rose 1.7% and Core FFO was $1.40 per share/unit; same-store cash NOI grew 0.8% (1.7% excluding a prior-year one-time recovery). The company improved net debt to adjusted EBITDA to 6.0x, ended the quarter with $259 million of available credit and no debt maturities until 2028, and issued $100 million of Series C convertible perpetual preferred equity. Management added senior-housing leadership and said future capital recycling will fund stabilized senior housing investments while evaluating further outpatient-portfolio dispositions. » Plus sur finance.yahoo.com

Global Medical REIT will release results for the quarter ended 31 Dec. 2025 on 25 Feb. 2026. Analysts expect EPS of $0.065 per share on average (prior year $0.100) and revenue of about $37.1 million (prior year $39.0 million). For the fiscal year just ended, the consensus forecast is a loss of -$0.260 per share versus a profit of $0.050 in the prior year; annual revenue is estimated at about $146.6 million (prior year $156.0 million). » Plus sur finanzen.net

Global Medical REIT announces that board member Henry Cole will leave the board at the end of his current term at the 2026 annual general meeting. Cole has served as an independent member since the company's founding and held leadership roles, including lead independent director and chair of the remuneration and ESG committees. Board chairman Jeffrey Busch praised Cole's contribution to guiding the REIT's growth and development. » Plus sur de.investing.com